Viewing Study NCT04140318


Ignite Creation Date: 2025-12-25 @ 4:46 AM
Ignite Modification Date: 2026-03-03 @ 4:32 AM
Study NCT ID: NCT04140318
Status: UNKNOWN
Last Update Posted: 2022-03-11
First Post: 2019-10-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sintilimab and Nab-paclitaxel in Second-line Treatment of Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma
Sponsor: Chinese Academy of Medical Sciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Gastric and Gastro-esophageal Junction Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None second line View
None PD-1 View
None nab-paclitaxel View